Effect of 2-methoxyestradiol on SK-LMS-1 uterine leiomyosarcoma cells

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• 2-methoxyestradiol (2-ME) is an endogenous 17β-estradiol metabolite with estrogen receptor affinity.
• 2-ME exhibits anti-proliferative effects and induces G2/M cell cycle arrest and apoptosis in various tumor cell types.
• Uterine leiomyosarcoma (ULMS) is a rare uterine malignancy requiring novel therapeutic strategies.

Purpose of the Study:

• To investigate the in vitro anti-proliferative effects of 2-ME on SK-LMS-1 human leiomyosarcoma cells.
• To evaluate the impact of 2-ME on apoptosis and autophagy in ULMS cells.
• To explore the underlying signaling pathways involved in 2-ME-induced cell death.

Main Methods:

• MTT assay for cell viability assessment.
• Terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) assay for apoptosis detection.
• Immunocytochemistry and Western blotting to analyze protein expression of apoptosis and autophagy markers, including light chain 3 and phosphorylated extracellular-signal-regulated kinase 1/2.

Main Results:

• A high concentration (10⁻⁵ M) of 2-ME demonstrated significant anti-proliferative effects on SK-LMS-1 cells.
• 2-ME treatment upregulated the expression of apoptosis markers and increased light chain 3, an autophagy marker, in a dose-dependent manner.
• Cell death was associated with the upregulation of the phosphorylated extracellular-signal-regulated kinase 1/2 signaling pathway.

Conclusions:

• 2-methoxyestradiol exhibits significant dose-dependent apoptotic and anti-proliferative effects on human uterine leiomyosarcoma cells.
• 2-ME demonstrates potential as a therapeutic reagent for human ULMS, warranting further investigation into optimal dosing.
• The study highlights the role of apoptosis, autophagy, and the ERK1/2 pathway in 2-ME-mediated anti-cancer activity.